Medication utilization patterns among patients with rheumatoid arthritis and coexisting autoimmune conditions
RA medication utilization varied significantly and may be influenced by comorbidities differently across RA drug classes. More research is needed to understand why therapies like tumor necrosis factor inhibitors persist longer in patients with RA with ulcerative colitis yet are discontinued earlier in patients with psoriatic arthritis.
Authors
- Jonathan P. DeShazo (ORCID: https://orcid.org/0000-0002-7997-6422)
- Catherine M. Lockhart (ORCID: https://orcid.org/0000-0001-7401-2205)
- Cheryl N. McMahill‐Walraven (ORCID: https://orcid.org/0000-0002-3765-6527)
- Érick Moyneur
- Aaron B. Mendelsohn (ORCID: https://orcid.org/0000-0002-0560-1177)
- Djeneba Audrey Djibo (ORCID: https://orcid.org/0000-0003-3378-0691)
Institutions
- Biogen (United States) (US)
- Oaks Hospital (GB)
- CVS Health (United States) (US)
Publication Details
- Journal
- Journal of Managed Care & Specialty Pharmacy
- Published
- 2025-10-31
- DOI
- https://doi.org/10.18553/jmcp.2025.31.11.1145
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00